EXEL Competitors & Alternatives
Compare Exelixis Inc with similar stocks in the same industry
Biotechnology
EXEL
Main Stock$55.06
Tradestie Score
47
Market Cap
$11.09B
P/E Ratio
17.6
Revenue Growth
0.1%
Analyst Upside
-5.4%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.17
|
$15.70B | 30.8 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.05
|
$15.22B | - | 57 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$166.23
|
$13.59B | 24.4 | 60 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$243.45
|
$12.36B | 28.1 | 54 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$33.32
|
$10.76B | - | 56 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$55.14
|
$10.74B | - | 51 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$60.00
|
$10.53B | 43.2 | 53 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$54.49
|
$10.49B | - | 59 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$79.96
|
$10.22B | - | 56 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$482.00
|
$10.01B | - | 52 | Compare |
More EXEL Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry